Abeona Therapeutics Inc vs Workday Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Workday Inc trades at $178.05 (market cap $44.77B). The key difference: Workday Inc is far larger — about 106.3× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Workday Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | WDAY | |
|---|---|---|
Market Cap | $421.19M | $44.77B |
Sector | Health | Technology |
52-Week High | $7.45 | $247.69 |
52-Week Low | $4.17 | $112.55 |
Enterprise Value | $276.10M | $44.22B |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →